COVID-19 Resource Center
COVID-19 Resource Center

Press release

Disclosures: Jayatilleke and Phillips report no relevant financial disclosures.
June 29, 2020
2 min read

ACR supports 'expanded role' for telemedicine in rheumatic care beyond COVID-19


Press release

Disclosures: Jayatilleke and Phillips report no relevant financial disclosures.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

The American College of Rheumatology has released a position statement in support of continued telemedicine access following the end of COVID-19 emergency measures, arguing it could help improve rheumatic care in the face of workforce shortages.

“The SARS-CoV-2 (COVID-19) pandemic has presented both challenges and opportunities to rheumatology professionals who have rapidly adopted telemedicine in routine practice,” Chris Phillips, MD, a member of the ACR’s Committee on Rheumatologic Care (CORC), said in a press release.

The ACR has released a position statement in support of continued telemedicine access following the end of COVID-19 emergency measures. Source: Adobe Stock

“As providers plan for rheumatology care post-COVID, taking into consideration rheumatology workforce shortages and geographically distant patients, it is apparent that telemedicine could help rheumatology providers improve care models for their patients if the long-term economic and regulatory landscape remains favorable,” he added.

Although rheumatology providers have advocated in the past for expansions in the use of telemedicine, their efforts have historically been hampered by federal and state regulations, reimbursement barriers and practical issues related to the provision of care, according to the ACR.

However, faced with a growing COVID-19 pandemic, federal and state officials have waived many of these restrictions, allowing rheumatology practices to provide telemedicine services, including audio-visual and audio-only visits, while curbing the disease’s spread and protecting staff and vulnerable patients.

Arguing that the value of telemedicine has been “undeniable” in preserving access and continuity of care, the ACR has crafted a series of eight position statements in favor of its continued, expanded role in rheumatology. These statements include support for the ongoing ability of patients to access telemedicine from their home following the end of the ongoing COVID-19 public health emergency, and opposition to geographic restrictions on telemedicine that limit its access to rural areas.

The ACR also declared support for continued parity of reimbursement for in-office visits, audio-visual visits and audio-only visits, both by CMS and by commercial payers, after the public health emergency has ended, so long as telemedicine services abide by four principles:

  • Provider-patient relationship includes both in-person and telemedicine services in accordance with the American Medical Association Code of Medical Ethics, and specifically the ethical practice in telemedicine;
  • Patients have a choice of telemedicine service provider;
  • Standards and scope of telemedicine care are consistent with in-person services, with the appropriate steps taken to mitigate the limitations of available technology;
  • The use of telemedicine services is properly documented.

Additionally, the statement calls for an end to payer policies that “dictate use of specified telemedicine platforms, use telemedicine services to construct restrictive networks, or which use telemedicine as a means to divert patients to their ‘preferred’ providers.”

Other provisions of the ACR position statement include support for:

  • An efficient mechanism to secure informed consent for telemedicine services;
  • Protocols to protect the security and integrity of patient information;
  • Policies that facilitate interstate telemedicine;
  • Outcomes-based research into the use of telemedicine in rheumatology.

According to the ACR, there remain several “areas of uncertainty” regarding telemedicine in rheumatology, despite promising preliminary evidence regarding its efficacy and cost-effectiveness. Outcomes-based research could potentially provide more information about the results of remote care and the best use of less frequent in-person visits, as well as provide validation of remote disease activity monitoring, the group added.

“While telemedicine should not replace many of the hands-on skills and in-office assessments rheumatology professionals provide, patients in all areas of the United States should have access to telemedicine, regardless of location, and the services should be included in all subscriber benefits and insurance plans,” Aruni Jayatilleke, MD, a member of CORC, said in the release. “Additionally, rheumatology professionals should be reimbursed equitably for telemedicine services and have access to a streamlined state medical license process.”